British Drugmaker GSK Said Its Antibody-based COVID-19 Therapy Developed with U.S. Partner ... - Latest Tweet by Reuters

British drugmaker GSK said its antibody-based COVID-19 therapy developed with U.S. partner Vir Biotechnology is effective against all mutations of the new Omicron coronavirus variant, citing new data from early-stage studies https://t.co/XnveVD8Hiz pic.twitter.com/KOHqdqmU32— Reuters (@Reuters) December 7, 2021

(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)